Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 58

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 8
Chunk 58
---
			(58,589,013
			)
			 
			$
			1,981,155

			Issuance of common shares

			3,862,803

			7,717,634

			-

			-

			-

			-

			-

			7,717,634

			Issuance of Series A-1 preferred shares and warrants

			-

			-

			998,915

			-

			541,905

			-

			-

			1,540,820

			Issuance of Series B-1 preferred shares

			-

			-

			-

			8,340,000

			-

			-

			-

			8,340,000

			Issuance of common shares upon exercise of restricted share units

			31,591

			71,748

			-

			-

			(71,748
			)

			-

			-

			-

			Issuance costs

			-

			(509,985
			)

			(43,220
			)

			(171,937
			)

			(23,446
			)

			-

			-

			(748,588
			)

			Preferred return on Series A-1 preferred shares

			-

			-

			136,438

			-

			-

			-

			(136,438
			)

			-

			Share-based compensation

			-

			-

			-

			-

			729,642

			729,642

			Net loss and comprehensive loss

			76,842

			(7,185,523
			)

			(7,108,681
			)

			Balance - September 30, 2025

			7,141,783

			$
			54,515,421

			$
			1,092,133

			$
			8,168,063

			$
			14,753,110

			$
			(165,771
			)
			 
			$
			(65,910,974
			)
			 
			$
			12,451,982

The accompanying notes